Jun Xue

488 total citations
27 papers, 322 citations indexed

About

Jun Xue is a scholar working on Surgery, Nephrology and Oncology. According to data from OpenAlex, Jun Xue has authored 27 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Nephrology and 6 papers in Oncology. Recurrent topics in Jun Xue's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Dialysis and Renal Disease Management (4 papers) and MRI in cancer diagnosis (2 papers). Jun Xue is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Dialysis and Renal Disease Management (4 papers) and MRI in cancer diagnosis (2 papers). Jun Xue collaborates with scholars based in China, United States and South Korea. Jun Xue's co-authors include Yong Gu, Mingxin Li, Shanyan Lin, Weixin Wang, K G Mann, C Kung, Michael Kalafatis, Jay R. Silveira, Ji-Hua Dong and Xiaofei Qu and has published in prestigious journals such as Journal of Clinical Oncology, Biochemistry and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Jun Xue

25 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun Xue China	9	78	75	51	37	35	27	322
Eman A. Elghoroury Egypt	12	134 1.7×	57 0.8×	18 0.4×	35 0.9×	20 0.6×	40	409
Peichun Zhang China	10	191 2.4×	181 2.4×	45 0.9×	18 0.5×	14 0.4×	12	404
Jing‐Min Zheng China	9	75 1.0×	113 1.5×	26 0.5×	37 1.0×	9 0.3×	14	390
Xinying Liu China	12	83 1.1×	73 1.0×	18 0.4×	64 1.7×	14 0.4×	48	341
Jiaxiang Ding China	12	110 1.4×	115 1.5×	10 0.2×	49 1.3×	14 0.4×	30	319
Lijun Zhao China	13	130 1.7×	214 2.9×	12 0.2×	51 1.4×	33 0.9×	47	540
Zhongzhi Tang China	11	138 1.8×	19 0.3×	31 0.6×	33 0.9×	17 0.5×	22	344
Qi Bian China	13	322 4.1×	223 3.0×	17 0.3×	66 1.8×	18 0.5×	25	681
Junhua Zhuang China	11	109 1.4×	19 0.3×	19 0.4×	23 0.6×	7 0.2×	37	338
Yingyan Zhou China	11	104 1.3×	20 0.3×	97 1.9×	42 1.1×	12 0.3×	31	364

Countries citing papers authored by Jun Xue

Since Specialization

Citations

This map shows the geographic impact of Jun Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Xue more than expected).

Fields of papers citing papers by Jun Xue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Xue. The network helps show where Jun Xue may publish in the future.

Co-authorship network of co-authors of Jun Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Xue. A scholar is included among the top collaborators of Jun Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Xue. Jun Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jin, Min, Shengli Yang, Lei Zhao, et al.. (2025). Effect of radiotherapy exposure on fruquintinib plus sintilimab treatment in refractory microsatellite stable metastatic colorectal cancer: a prospective observation study. Journal for ImmunoTherapy of Cancer. 13(1). e009415–e009415. 4 indexed citations

Xue, Jun, et al.. (2023). 958P Preliminary results of radiotherapy (RT) combined with sintilimab (Sin) and bevacizumab (Bev) in advanced hepatocellular carcinoma (HCC) previously treated with immune checkpoint inhibitors (ICIs): A prospective phase II study. Annals of Oncology. 34. S599–S599. 1 indexed citations

Wang, Jianhua, Jing Yao, Xiaoye Zhu, et al.. (2023). Impact of frequent intradialytic hypotension on quality of life in patients undergoing hemodialysis. BMC Nephrology. 24(1). 209–209. 6 indexed citations

Shi, Hongyun, Chao Li, Zhengliang Chen, et al.. (2022). Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched Study. International Journal of Radiation Oncology*Biology*Physics. 114(2). 238–249. 5 indexed citations

Wang, Zuoyuan, Li You, Xiaoye Zhu, et al.. (2022). Finasteride Alleviates High Fat Associated Protein-Overload Nephropathy by Inhibiting Trimethylamine N-Oxide Synthesis and Regulating Gut Microbiota. Frontiers in Physiology. 13. 900961–900961. 7 indexed citations

Guo, Yuan, Qingcong Kong, Wenjie Tang, et al.. (2021). Whole Volume Apparent Diffusion Coefficient (ADC) Histogram as a Quantitative Imaging Biomarker to Differentiate Breast Lesions: Correlation with the Ki‐67 Proliferation Index. BioMed Research International. 2021(1). 4970265–4970265. 10 indexed citations

Zhang, Qian, Lingyun Lai, Yuanyuan Cai, et al.. (2021). Serum-Urine Matched Metabolomics for Predicting Progression of Henoch-Schonlein Purpura Nephritis. Frontiers in Medicine. 8. 657073–657073. 7 indexed citations

Li, Yi, Xin Li, Yuancheng Chen, et al.. (2021). Nemonoxacin dosage adjustment in patients with severe renal impairment based on population pharmacokinetic and pharmacodynamic analysis. British Journal of Clinical Pharmacology. 87(12). 4636–4647. 5 indexed citations

Hua, Qingling, Dejun Zhang, Yunqiao Li, et al.. (2021). Prognostic Factors of Survival of Advanced Liver Cancer Patients Treated With Palliative Radiotherapy: A Retrospective Study. Frontiers in Oncology. 11. 658152–658152. 4 indexed citations

10.

Hu, Yue, Tingting Qin, Shuang Li, Tao� Zhang, & Jun Xue. (2020). Efficacy and Safety of SBRT Combined With Camrelizumab and Apatinib in HCC Patients With PVTT: Study Protocol of a Randomized Controlled Trial. Frontiers in Oncology. 10. 1589–1589. 18 indexed citations

11.

Wang, Fan, et al.. (2019). Renal Outcomes of Pregnant Patients with Immunoglobulin A Nephropathy: A Systematic Review and Meta-Analysis. American Journal of Nephrology. 49(3). 214–224. 10 indexed citations

12.

Jose, Shinsmon, Mayuresh M. Abhyankar, Jun Xue, et al.. (2018). Leptin receptor q223r polymorphism influences neutrophil mobilization after Clostridium difficile infection. Mucosal Immunology. 11(3). 947–957. 8 indexed citations

13.

Lin, Zhenyu, Junli Liu, Li Peng, et al.. (2018). Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report. BMC Cancer. 18(1). 1253–1253. 4 indexed citations

14.

Wang, Jia, Qionghong Xie, Zhuxing Sun, et al.. (2017). Response to immunosuppressive therapy in PLA2R- associated and non-PLA2R- associated idiopathic membranous nephropathy: a retrospective, multicenter cohort study. BMC Nephrology. 18(1). 227–227. 15 indexed citations

15.

Zhang, Weimin, Changlin Mei, Nan Chen, et al.. (2015). Improving Adequacy of Hemodialysis in Shanghai: Perspectives From the Quality Control Group of the Shanghai Renal Registry Network (SRRN). 56. 78–83. 1 indexed citations

16.

Xue, Jun, Ji-Hua Dong, Guodong Huang, et al.. (2014). NF-κB signaling modulates radiation-induced microglial activation. Oncology Reports. 31(6). 2555–2560. 32 indexed citations

17.

Ji, Yanan, Qin Wang, & Jun Xue. (2013). TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis. Tumor Biology. 35(2). 1653–1659. 6 indexed citations

18.

Xue, Jun, Lili Chen, Qianqian Xu, et al.. (2012). SU-E-J-152: Prostate IGRT: CT-MRI Fusion and Target Delineation Accuracy. Medical Physics. 39(6Part8). 3687–3687. 1 indexed citations

19.

Li, Mingxin, Weixin Wang, Jun Xue, Yong Gu, & Shanyan Lin. (2010). Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy. Journal of Ethnopharmacology. 133(2). 412–419. 116 indexed citations

20.

Xue, Jun, et al.. (2007). Effects of HELP Therapy on Acute Ischemic Stroke and Vascular Endothelial Cell Function. Therapeutic Apheresis and Dialysis. 11(3). 171–176. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact